Rasuvo
NDC 59137-505, methotrexate, injection, solution, from Medexus Pharma Inc..
- Product NDC
- 59137-505
- Status
- Listed
- Labeler
- Medexus Pharma Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA205776
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59137-505 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE SODIUM7.5 mg/.15mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59137-505-01 | 59137050501 | 1 PACKAGE in 1 CARTON (59137-505-01) / .15 mL in 1 PACKAGE (59137-505-00) |
| 59137-505-04 | 59137050504 | 4 PACKAGE in 1 CARTON (59137-505-04) / .15 mL in 1 PACKAGE (59137-505-00) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d0075461-0e7e-4967-9c9b-d6440e912c0eNADAC price for package 59137050504
GET /v1/drugs/nadac/59137050504
Use it
Look up 59137-505 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59137-505 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59137-505. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.